ProCE Banner Activity

Focus on Therapy for MET Exon 14 Mutations in Advanced NSCLC

Slideset Download
Find expert insight on MET exon 14 skipping mutations in NSCLC with a focus on current therapeutic approaches to targeting MET in this downloadable slideset.

Released: August 31, 2020

Expiration: August 30, 2021

No longer available for credit.

Share

Faculty

Gregory J. Riely

Gregory J. Riely, MD, PhD

Associate Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Enriqueta Felip

Enriqueta Felip, MD

Head, Thoracic Oncology Unit
Oncology Service
Vall d Hebron University Hospital
Barcelona, Spain

Paul K. Paik

Paul K. Paik, MD

Assistant Attending
Clinical Director, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This educational activity is supported by an independent grant from the Healthcare business of

Merck KGaA

Program Director Disclosure

Program Director

Gregory J. Riely, MD, PhD

Associate Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Faculty Disclosure

Primary Author

Enriqueta Felip, MD

Head, Thoracic Oncology Unit
Oncology Service
Vall d Hebron University Hospital
Barcelona, Spain

Paul K. Paik, MD

Assistant Attending
Clinical Director, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York